Seasonal Influenza Vaccine Effectiveness in Persons Aged 15–64 Years: A Systematic Review and Meta-Analysis

Seasonal Influenza Vaccine Effectiveness in Persons Aged 15–64 Years: A Systematic Review and Meta-Analysis

Influenza is a respiratory disease caused by the influenza virus, which is highly transmissible in humans. This paper presents a systematic review and meta-analysis of randomized controlled trials (RCTs) and test-negative designs (TNDs) to assess the vaccine effectiveness (VE) of seasonal influenza...

Full description

Bibliographic Details
Main Authors:	João Paulo Martins, Marlene Santos, André Martins, Miguel Felgueiras, Rui Santos
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Vaccines
Subjects:	influenza test-negative design clinical trials efficacy effectiveness strains
Online Access:	https://www.mdpi.com/2076-393X/11/8/1322

Similar Items

Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season
by: Chunna Ma, et al.
Published: (2017-10-01)

Rapid safety assessment of a seasonal intradermal trivalent influenza vaccine
by: Marc Demeulemeester, et al.
Published: (2017-04-01)

Clinical Advances in Viral-Vectored Influenza Vaccines
by: Sarah Sebastian, et al.
Published: (2018-05-01)

CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU
by: M. K. Erofeeva, et al.
Published: (2014-07-01)

Efforts to Improve the Seasonal Influenza Vaccine
by: Alfred T. Harding, et al.
Published: (2018-03-01)

Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
by: Viviane Gresset-Bourgeois, et al.
Published: (2018-01-01)

Recommendations for the Clinical Development of Medicinal Products for Non-specific Influenza Chemoprophylaxis
by: A. I. Gubenko, et al.
Published: (2024-04-01)

Immunogenicity and safety of seasonal influenza vaccines in children under 3 years of age
by: Tia Aoun, et al.
Published: (2023-12-01)

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
by: Louise Murdoch, et al.
Published: (2023-09-01)

A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade
by: Brigette N. Corder, et al.
Published: (2020-10-01)

Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults
by: Goran Stevanovic, et al.
Published: (2018-03-01)

New Kids on the Block: RNA-Based Influenza Virus Vaccines
by: Francesco Berlanda Scorza, et al.
Published: (2018-04-01)

Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial
by: Qinhai Ma, et al.
Published: (2022-08-01)

CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF BETALEUKIN IN PATIENTS WITH INFLUENZA AND FLU-LIKE DISEASES COMPLICATED BY PNEUMONIA
by: L. V. Voloschchuk, et al.
Published: (2014-07-01)

Corrigendum: Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial
by: Qinhai Ma, et al.
Published: (2023-01-01)

Safety of a quadrivalent influenza vaccine in Vietnamese healthy subjects aged 6 months and older
by: Vu Dinh Thiem, et al.
Published: (2021-03-01)

Recommendations for the programme of clinical trials of medicinal products for the treatment of influenza
by: A. I. Gubenko, et al.
Published: (2023-12-01)

Influenza Vaccine Effectiveness Estimates among US Department of Defense Adult Beneficiaries over Four Consecutive Influenza Seasons: A Test-Negative Design Study with Different Control Groups
by: Wenping Hu, et al.
Published: (2021-12-01)

A severe 2017 influenza season dominated by influenza A(H3N2), Victoria, Australia
by: Carville KS, et al.
Published: (2019-09-01)

Characteristics of clinical trials of influenza and respiratory syncytial virus registered in ClinicalTrials.gov between 2014 and 2021
by: David Lora, et al.
Published: (2023-09-01)

Clinical and laboratory characteristics of influenza infection in hospitalized adult patients during the 2018-2019 epidemic season
by: L. V. Voloshchuk, et al.
Published: (2021-02-01)

Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults
by: Joseph Eiden, et al.
Published: (2021-11-01)

Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine
by: Ian McGovern, et al.
Published: (2024-12-01)

The role of cell-mediated immunity against influenza and its implications for vaccine evaluation
by: Yorick Janssens, et al.
Published: (2022-08-01)

Avian Influenza in Wild Birds and Poultry: Dissemination Pathways, Monitoring Methods, and Virus Ecology
by: Artem Blagodatski, et al.
Published: (2021-05-01)

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: a double-blind, randomized, parallel-controlled phase III clinical trial in China
by: Shi-Yuan Wang, et al.
Published: (2017-11-01)

Influenza vaccine effectiveness in patients hospitalized with severe acute respiratory infection in Lithuania during the 2019–2020 influenza season: a test negative case – control study
by: Roberta Vaikutyte, et al.
Published: (2023-04-01)

Seroepidemiological Findings in 1996-1997 Influenza Season
by: Neziha YILMAZ, et al.
Published: (1997-12-01)

The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence
by: Serena Marchi, et al.
Published: (2023-08-01)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
by: Zhaojun Mo, et al.
Published: (2017-06-01)

Influence of Prior Influenza Vaccination on Current Influenza Vaccine Effectiveness in Children Aged 1 to 5 Years
by: Kazuhiro Matsumoto, et al.
Published: (2021-12-01)

Models for predicting the evolution of influenza to inform vaccine strain selection
by: Joseph K. Agor, et al.
Published: (2018-03-01)

Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe: results from the DRIVE multi-stakeholder study platform
by: Anke L. Stuurman, et al.
Published: (2023-07-01)

Moderate influenza vaccine effectiveness against influenza A(H1N1)pdm09 virus and low effectiveness against A(H3N2) virus among older adults during 2013–2014 influenza season in Beijing, China
by: Li Zhang, et al.
Published: (2018-06-01)

Systematic Review of Equine Influenza A Virus Vaccine Studies and Meta-Analysis of Vaccine Efficacy
by: Sol Elliott, et al.
Published: (2023-11-01)

Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics
by: Kaori Sano, et al.
Published: (2018-08-01)

Influenza season - is there anything to worry about?
by: Maciej Dubaj, et al.
Published: (2021-09-01)

Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects
by: Won Suk Choi, et al.
Published: (2017-07-01)

Immunogenicity, Safety, and Efficacy of Influenza Vaccine in T2DM and T2DM with Chronic Kidney Disease
by: Henhen Heryaman, et al.
Published: (2024-02-01)

Molecular mutation features of influenza B viruses in Guangdong, 2020-2021
by: TAN Jing, et al.
Published: (2022-09-01)